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INTRODUCTION 
Epithelioid hemangioendothelioma (EHE) is a low-grade malignant neoplasm derived from endothelial cells. 
It was first recognized in soft tissues (l), with later reports showing that the liver may also serve as a primary 
site (2). We have treated 17 cases of primary hepatic EHE with orthotopic liver transplantation (OLT), and 
they are the subject of this report. 
CASE MATERIALS AND :METHODS 
A) Patient profile: 
Between November 1976 and February 19<)3, 17 patients with the diagnosis of EHE were treated with OLT 
either at the University Health Sciences Center of Culorado (I 971-19S0) or at the University of Pittsburgh 
Medical Center (1981-1993). There were ~ males and l) rem ales, with t heir ages ranging from O~ to 58 years 
(mean of 36 years). Follow-up intervals ranged from I to 15 years (median of 4.7 years). 
B) Clinical Features: 
The most common prcsenlatiun was abdominal pdin and hepatomegaly. ies~ comlllon signs and symptoms 
included weight loss, jaundice, fatigue, anorexia, ~lKIeitesI shoulder pain, splenomegaly, and d\'spm;a (Table I). 
In five patients the tumor was found incidentally: in [wo patients during follow-up for previously treated 
cancer (squamous cell carcinoma of the nasopharynx and melanoma \If the hack). in one patient during 
evaluation of a back injury. in one patient during a laparotomy for endometriosis, and, finally, one patient 
discovered mUltiple lesions in her liver while pnforming an ultrasound examination on herself. Four of the 
nine women h;ld taken oral contraceptives for indeterminate periods. No patient in this series had a history 
of l:xposure to hcpatotoxins. 
C) Diagnosis: 
In fourteen patients the diagnosis was conlirmed prior to transpLintatioll: in ~cyDen bv perclltaneous liver 
hiopsy and in seven by open liver hiopsy. In the remaining three gl~ltients the diagnosis was ohtained at the 
---~D--"------"""-"" 
time of the transplant. 
Five patients had been originally misdiagnosed. In three cases, I to 5 years prior to transplant, the liver 
hiopsies were interpreted as hemangiomas (and one of these patients had a separate biopsy interpreted as a 
sarcoma). One patient was thought to have a hemangioma, a diagnosis he carried for 15 years without 
biopsy support, and only when the development of liver failure necessitated transplantation was the real 
nature of these lesions established. The last patient had a non-diagnostic percutaneous biopsy. 
The extent of tumor was staged according to the TNM classification ( 3,4). Fifteen patients were stage IV-
A and two were stage IV-B. 
D) Treatment: 
All patients underwent a standard orthotopic liver transplantation (5). The first patient in our series also had 
a concomitant excision of a pulmonary nodule. Five patients received chemotherapy with Adriamycin-based 
regimens: one preoperative, three postoperative, and in one case before and after the transplant. An 
additional three patients had radiotherapy, two preoperatively amI one after surgt:ry. Baseline 
immunosuppression was accomplished with azathioprine and prednisone in one patient, cyciosporine and 
prednisone in 11 patients and FK50(i in the remaining 5 patients. 
E) Statistical Analysis: 
Kaplan-Meir curves were used for survival an;dysis. Ditlcrences between groups were tested for signiiieance 
using Breslow's test. with the significance level set at (J.().'). 
RESULTS 
Actuarial patient surviv;d at L .3. and:; year was IO()';. S(,<-;. and IlY;. respectivelv. Nine oi' 17 patients 
C,:;':;) arc alive and free of tumor: 7 lli' the~e patients have had Idiow·up intenais greater than.') years 
(median of 7.5 years). One patient died of chronic rejection. withlllll tumor. 10 months alter OL T. Diffuse 
metastatic disease was responsible for death in liv~ patients. Two pati~nts arc ali\'e with metastases: on~ with 
lung metastases three years after surgery, and the other with tumor in the liver four years after her 
transplant. This last patient was re-transplanted but, unfortunately, there was residual tumor at the margins 
of the resection. 
Disease-free survival at 1, 3, and 5 years was b8%, Sh~D~I and 59'/r). respectively (Fig. I). The most common 
sites of recurrence were the liver, lung, and bone. Involvement of the hilar lymph nodes or vascular invasion 
were frequent features, being present in nine patients (52%). Yet half of those patients arc currenLiy alive 
and frce of disease. There was no difference in the recurrence rates among patients with positive or negative 
nodes (Fig. 2). Likewise, vascular invasion did not affect the recurrence rate (Fig. 3). 
There were six postoperative complications that occurred in live patients. One patient bled lrom the Roux-
en-Y loop requiring exploration on the fourth post-operative day. Eight months later he developed a biliary 
stricture that required percutaneous dilatation. Two patients needed a second graft because 01 primary 
nonfunction, at two and four days post-transplant. One patient required thrombectomy on the fourth post-
operative day due to hepatic artery thrombosis. Finallv, one patient that received a second graft (for liver 
recurrence, [our years after the primary transplant), developed a biliary leak and intra-abdominal abscess, 10 
and 14 days after her re-transplant. She was evenlllally discharged, following a prolonged hospital course. 
All patients recovered from their complications. 
DISCUSSION 
Epithelioid hemangioendllthelioma is a soft tisslH.! mali\lnant tumor that is characterized by its epithelial-like 
:lppearance and vascular endothelial histogencsis. It \\as histologic;dly identilied by Weiss and Enzinger in 
1()s2 (1), and in 19~4 Ishak et aI., tirst reported a series of 32 primary EHE of the liver (2). In 1<F~UI we 
reported the lirst serics ()f patients (10 cases) (()) with llnresectabk EHE that were treated with liver 
transplantation. This report updates that initi:t\ series, :lIld adds an additional scven cases that wc havc 
treated since. 
Lin:r transplantation for hepatic malignancv remains .\urrollnded by cllIltrmcrsv, stemming frlll11 the fact that 
hepatocellular carcinomas and cho/ang,iocarcinomas an: :lssociated with a high recurrence r:lte :lfter liver 
transplantation (7,8). 
The clinical presentation of EHE is usually non-s[lecific. The trut: incidt:nce of this tumor is not yet known, 
and it is possible that many of these tumors have been misdiagnosed. especially before Ishak's rt:port in 1984 
(9). The only risk factors known in these patit:nts wert: the usc of oral contraceptives (10). The final 
diagnosis of this neoplasm requires interpretation supplemented by immunohistochemical staining (2). Often, 
a wedge biopsy of the tumor is necessary to recognize the architectural features such as the intravascular or 
intrasinusoidal growth pattern characteristic of tht: neoplasm (2, 11). Bt:cause of the variable cellularity within 
any given tumor nodule, needk biopsy may be non-diagnostic if only a fibrous tissue area is sampled. 
Relying on only the cytologic appearance may rt:sult in overgrading the lesion as a highly malignant 
angiosarcoma, rather than a low grade malignancy. This, obviously, could result in limiting the treatment plan 
to conservative medical management, excluding the possibility of a liver transplant. In point of fact, 5 of 17 
patients in the current series had an initial incorrect diagnosis. 
A direct comparison between the report of Ishak t:t al.,(2), of 32 patients with EH E, and thl: current series 
of 17 patients treated with livt:r transplantation, is not possibk. Howcver, it is interesting to note that only 
ninl: of 32 (281;'0 of the Ishak l:l aI., patients survi\\:d mOlT than live years. The actuarial survival rate of the 
EHE patients treated with livt:r transplantation in the current seril:s (117';;, at :) years) is satisfactory, and 
compares favorably with that sel:n in patil:nts transplanted for nonmalignant disl:ase (12). 
Obviously, it remains dil'licuit to propOSl: a single standard therapeutic approach for thl:Sl: tUl1lors because of 
their rarity and unpredictable natural histnry. Long-term survival without any specilic therapy has bl:en 
reported by Ishak el al. in primary hepatic EHE (nine of thl:ir 30 patients survived more than livl: Yl:ars) (2). 
According to Weiss and Enzinger (1) the histologic features of EH E do not predict tumor hehavior, and 
consl:quently it is not possible to USl: thl: histologic ch;lf<lcteristic of a giwn liver EHE as a t,(uide for 
therapeutic dl:cisions. Hepatic EHE is usually l1lultifm:al (1.2.11) and. therclorl:. not suitabk fl1r partial 
hl:patectomy (6,13.1-+). Thus. total hepatectomy and OLT is the surt,(icaltherapl:utie procedure of choicl:. 
The long-term survival ;lI1d di:--easc-Ircc suni\'al alter li\'Cr tranSpbl1t;ltilln ("epurted ill this paper puts EHE 
into a unique cilegory of primary li\er tumors. E\en fll\lowing the de\elllpmCnl 01 melastases lhrt:l: patienls 
survived for more than two years. It is also interesting that even in the presence of vascular invasion and 
positive hilar lymph nodes at transplant (findings that usually condemn to a rapid death from recurrence in 
all the other primary liver tumors), nine patients arc alive and free of disease. Seven paticnts recurred, and 
live of them died as a result of it. The survival \vas similar in patients with positive and negative nodes. We 
do not have sufficient data to define a role for chemotherapy, radiotherapy, or both in the treatment of this 
neoplasm. Thus, prospective studies will be required in this area. Also, it is not known whether lymph node 
dissection in conjunction with the liver transplant would affect survival. In this series. however, lymph node 
dissection was not systematically performed. 
In conclusion. liver transplantation appears to be a wrv reasonable therapeutic approach for hepatic EHE 
when the tumor is not resectable (other than with a total hepatectomy). The long-Ierm survival obtained in 
this series justifies liver transplantation for these tumors even in the presence of limited extra-hepatic disease. 
TABLE 1: CLINICAL PRESENTATION 
SYMPTOMS AND SIGNS # OF CASES l\IEAN DURATION 
(IN MONTHS) 
ABDOMINAL PAIN 'i 12.S 
WEIGHT LOSS 3 10 
FATIGUE 1 2 
ANOREXIA 1 () 
JAUNDICE 2 (i.S 
ASCITES 1 12 
SHOULDER PAIN 1 1 
SPLENOMEGALY 1 24 
DYSPNEA 1 2 
CHOLANGITIS 1 1 
HEPATOMEGALY 4 7 
INCIDENTAL .'\ S 
1. 
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